These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 28109164)

  • 1. Assessment of biological, psychological and adherence factors in the prediction of step-down treatment for patients with well-controlled asthma.
    Saito N; Kamata A; Itoga M; Tamaki M; Kayaba H; Ritz T
    Clin Exp Allergy; 2017 Apr; 47(4):467-478. PubMed ID: 28109164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dispensation of long-acting β agonists with or without inhaled corticosteroids, and risk of asthma-related hospitalisation: a population-based study.
    Sadatsafavi M; Lynd LD; Marra CA; FitzGerald JM
    Thorax; 2014 Apr; 69(4):328-34. PubMed ID: 24281327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long-acting beta-agonist inhaler therapy in asthma.
    Perrin K; Williams M; Wijesinghe M; James K; Weatherall M; Beasley R
    J Allergy Clin Immunol; 2010 Sep; 126(3):505-10. PubMed ID: 20816187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A clinical study on the significance of airway hyperresponsiveness monitoring in the adjustment of combined therapy for asthmatic patients].
    Liu CT; Wang YM; Wang G; Tan CW; Pang YM
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jul; 30(7):498-503. PubMed ID: 17961403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of congenital malformations for asthmatic pregnant women using a long-acting β₂-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy.
    Eltonsy S; Forget A; Beauchesne MF; Blais L
    J Allergy Clin Immunol; 2015 Jan; 135(1):123-30. PubMed ID: 25226849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with adherence to asthma treatment with inhaled corticosteroids: A cross-sectional exploratory study.
    Adouni Lawani M; Zongo F; Breton MC; Moisan J; Grégoire JP; Dorval E; Boulet LP; Jobin MS; Guénette L
    J Asthma; 2018 Mar; 55(3):318-329. PubMed ID: 28471286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revising old principles of inhaled treatment in new fixed combinations for asthma.
    Scichilone N; Rossi A; Melani A
    Pulm Pharmacol Ther; 2015 Aug; 33():32-8. PubMed ID: 26079566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world effects of two inhaled corticosteroid/long-acting β₂-agonist combinations in the treatment of asthma.
    Yatera K; Yamasaki K; Nishida C; Noguchi S; Oda K; Akata K; Nagata S; Kawanami Y; Kawanami T; Ishimoto H; Mukae H
    J Asthma; 2014 Sep; 51(7):762-8. PubMed ID: 24654703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-year outcomes of inhaled controller therapies added to systemic corticosteroids after asthma-related hospital discharge.
    Sadatsafavi M; Lynd LD; De Vera MA; Zafari Z; FitzGerald JM
    Respir Med; 2015 Mar; 109(3):320-8. PubMed ID: 25596136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
    Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
    Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stepping down inhaled corticosteroids from scheduled to as needed in stable asthma: Systematic review and meta-analysis.
    Gionfriddo MR; Hagan JB; Hagan CR; Volcheck GW; Castaneda-Guarderas A; Rank MA
    Allergy Asthma Proc; 2015; 36(4):262-7. PubMed ID: 26108083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of anti-inflammatory effect from addition of a long-acting beta-2 agonist to inhaled corticosteroid.
    Shimoda T; Obase Y; Kishikawa R; Mukae H; Iwanaga T
    Allergy Asthma Proc; 2016 Sep; 37(5):387-93. PubMed ID: 27657522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of switching low-dose inhaled corticosteroid to pranlukast for step-down therapy in well-controlled patients with mild persistent asthma.
    Harada S; Harada N; Itoigawa Y; Katsura Y; Kasuga F; Ishimori A; Makino F; Ito J; Atsuta R; Takahashi K
    J Asthma; 2016; 53(2):207-12. PubMed ID: 26325232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing adherence to inhaled corticosteroids in asthma patients using an integrated measure based on primary and secondary adherence.
    Blais L; Kettani FZ; Forget A; Beauchesne MF; Lemière C; Ducharme FM
    Eur J Clin Pharmacol; 2017 Jan; 73(1):91-97. PubMed ID: 27695918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to anti-inflammatory treatment for asthma in clinical practice in France.
    Latry P; Pinet M; Labat A; Magand JP; Peter C; Robinson P; Martin-Latry K; Molimard M
    Clin Ther; 2008; 30 Spec No():1058-68. PubMed ID: 18640480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of an asthma integrated care program on asthma control and adherence to inhaled corticosteroids.
    Guénette L; Breton MC; Grégoire JP; Jobin MS; Bolduc Y; Boulet LP; Dorval E; Moisan J
    J Asthma; 2015; 52(6):638-45. PubMed ID: 25539138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and outcomes in patients with asthma and allergic rhinitis in the United kingdom.
    Zhang Q; Thomas M; Wisniewski T; Sazonov Kocevar V; Price D
    Int Arch Allergy Immunol; 2007; 142(4):318-28. PubMed ID: 17135763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empowering pharmacists in asthma management through interactive SMS (EmPhAsIS): study protocol for a randomized controlled trial.
    De Vera MA; Sadatsafavi M; Tsao NW; Lynd LD; Lester R; Gastonguay L; Galo J; FitzGerald JM; Brasher P; Marra CA
    Trials; 2014 Dec; 15():488. PubMed ID: 25494702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of budesonide/formoterol maintenance and reliever therapy with fluticasone/salmeterol fixed-dose treatment on airway inflammation and small airway impairment in patients who need to step-up from inhaled corticosteroid monotherapy.
    Hozawa S; Terada M; Hozawa M
    Pulm Pharmacol Ther; 2014 Apr; 27(2):190-6. PubMed ID: 24388868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.